Michael  Lane net worth and biography

Michael Lane Biography and Net Worth

Mr. Lane has been an Executive Vice President of IDEXX since January 2020 and previously served as a Corporate Vice President from July 2015 to January 2020 and a Vice President from 2012 to July 2015. He has been the General Manager of IDEXX's Global Reference Laboratories business since November 2016, with a portfolio that also currently includes the company's worldwide Information Technology, Telemedicine business and IDEXX BioAnalytics. Prior to becoming the General Manager of our Global Reference Laboratories business, he served as the General Manager of the company's U.S. Reference Laboratories from June 2014 to November 2016. In addition to his responsibilities for the Reference Laboratories business, from July 2015 through December 2016, Mr. Lane provided strategic direction for the company's SNAP Point-of-Care testing. In 1999, he joined the IDEXX VetLab organization, where he held various leadership positions with responsibilities in commercial marketing, product management, and new product development, and served as General Manager from 2012 to 2014. Mr. Lane joined IDEXX in 1997, supporting strategic planning and business development for diagnostic laboratory services as IDEXX entered the global reference laboratory market segment. Mr. Lane holds a bachelor's degree in international politics and economics from Middlebury College and an MBA from the Tuck School of Business at Dartmouth College.

What is Michael Lane's net worth?

The estimated net worth of Michael Lane is at least $2.17 million as of August 3rd, 2023. Mr. Lane owns 4,034 shares of IDEXX Laboratories stock worth more than $2,172,309 as of December 11th. This net worth estimate does not reflect any other assets that Mr. Lane may own. Additionally, Mr. Lane receives a salary of $891,100.00 as EVP at IDEXX Laboratories. Learn More about Michael Lane's net worth.

How old is Michael Lane?

Mr. Lane is currently 55 years old. There are 5 older executives and no younger executives at IDEXX Laboratories. The oldest executive at IDEXX Laboratories is Mr. Jonathan J. Mazelsky, President, CEO & Director, who is 62 years old. Learn More on Michael Lane's age.

What is Michael Lane's salary?

As the EVP of IDEXX Laboratories, Inc., Mr. Lane earns $891,100.00 per year. There are 2 executives that earn more than Mr. Lane. The highest earning executive at IDEXX Laboratories is Mr. Jonathan J. Mazelsky, President, CEO & Director, who commands a salary of $2,040,000.00 per year. Learn More on Michael Lane's salary.

How do I contact Michael Lane?

The corporate mailing address for Mr. Lane and other IDEXX Laboratories executives is ONE IDEXX DRIVE, WESTBROOK ME, 04092. IDEXX Laboratories can also be reached via phone at (207) 556-0300 and via email at [email protected]. Learn More on Michael Lane's contact information.

Has Michael Lane been buying or selling shares of IDEXX Laboratories?

Michael Lane has not been actively trading shares of IDEXX Laboratories during the last ninety days. Most recently, Michael Lane sold 16,027 shares of the business's stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $510.00, for a transaction totalling $8,173,770.00. Following the completion of the sale, the executive vice president now directly owns 4,034 shares of the company's stock, valued at $2,057,340. Learn More on Michael Lane's trading history.

Who are IDEXX Laboratories' active insiders?

IDEXX Laboratories' insider roster includes Jonathan Ayers (Director), Bruce Claflin (Director), Rebecca Henderson (Director), Nimrata Hunt (EVP), Daniel Junius (Director), Michael Lane (EVP), Jonathan Mazelsky (CEO), Brian Mckeon (CFO), James Polewaczyk (EVP), M. Szostak (Director), Kathy Turner (SVP), Kathy Turner (SVP), Giovani Twigge (SVP), and Sophie Vandebroek (Director). Learn More on IDEXX Laboratories' active insiders.

Are insiders buying or selling shares of IDEXX Laboratories?

During the last year, insiders at the sold shares 10 times. They sold a total of 87,311 shares worth more than $44,388,246.86. The most recent insider tranaction occured on December, 7th when EVP James F Polewaczyk sold 11,636 shares worth more than $6,071,548.44. Insiders at IDEXX Laboratories own 2.1% of the company. Learn More about insider trades at IDEXX Laboratories.

Information on this page was last updated on 12/7/2023.

Michael Lane Insider Trading History at IDEXX Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/3/2023Sell16,027$510.00$8,173,770.004,034View SEC Filing Icon  
5/5/2023Sell1,000$484.00$484,000.004,022View SEC Filing Icon  
8/3/2021Sell6,999$691.62$4,840,648.38View SEC Filing Icon  
11/3/2020Sell1,304$443.00$577,672.00View SEC Filing Icon  
8/5/2019Sell17,961$264.10$4,743,500.10View SEC Filing Icon  
5/10/2019Sell1,812$245.41$444,682.92View SEC Filing Icon  
2/20/2019Sell736$211.58$155,722.886,468View SEC Filing Icon  
2/15/2019Sell971$208.00$201,968.00View SEC Filing Icon  
8/21/2018Sell5,912$243.78$1,441,227.36View SEC Filing Icon  
See Full Table

Michael Lane Buying and Selling Activity at IDEXX Laboratories

This chart shows Michael Lane's buying and selling at IDEXX Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

IDEXX Laboratories Company Overview

IDEXX Laboratories logo
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Read More

Today's Range

Now: $536.12
Low: $531.59
High: $541.19

50 Day Range

MA: $447.27
Low: $391.37
High: $531.35

2 Week Range

Now: $536.12
Low: $372.50
High: $564.73


521,212 shs

Average Volume

468,295 shs

Market Capitalization

$44.52 billion

P/E Ratio


Dividend Yield